Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-16

Clinical Trial Update: A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating patients with smoldering and active multiple myeloma is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Landspitali University Hospital | Conditions: Multiple Myeloma, Smoldering Multiple Myeloma | Phase 2 | Status: ENROLLING_BY_INVITATION